Oral Tegafur-Uracil Combination plus Leucovorin versus Other Fluoropyrimidine Agents in Colorectal Cancer: A Systematic Review and Meta-Analysis

Background  Systemic fluoropyrimidines, both oral and intravenous, are an integral part of colorectal cancer (CRC) management. They can be administered either with curative or palliative intent. Objectives  This article examines the literature to analyze the efficacy and safety of the oral fixed-dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataria, Satya Pal, Nagar, Mukesh, Verma, Shikha, Purohit, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273330/
https://www.ncbi.nlm.nih.gov/pubmed/35833043
http://dx.doi.org/10.1055/s-0041-1735650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273330/
https://www.ncbi.nlm.nih.gov/pubmed/35833043
http://dx.doi.org/10.1055/s-0041-1735650

Ejemplares similares